The decreased serum levels of interleukin-38 in patients with gout and its clinical significance
The findings suggest that the decreased serum levels of IL-38 in patients with gout compared to that in NCs indicates that IL-38 may have immunomodulatory effects on gout inflammation and possesses clinical application value.
Authors
- Hua Huang (ORCID: https://orcid.org/0000-0002-0914-6562)
- Xiudi Wu (ORCID: https://orcid.org/0000-0001-5705-7161)
- Mingcai Li (ORCID: https://orcid.org/0000-0003-3910-6964)
- Yinxin Zhou
- Hui Zhao (ORCID: https://orcid.org/0000-0001-8554-9411)
- Yan Li (ORCID: https://orcid.org/0000-0003-3517-8055)
Institutions
- Ningbo University (CN)
- Ningbo University Affiliated Hospital (CN)
- Ningbo No.6 Hospital (CN)
- Ningbo First Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-10-17
- DOI
- https://doi.org/10.3389/fimmu.2024.1434738
- Citations
- 1
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 0.34
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Ningbo